165.81 0.00 (0.00%)
After hours: 5:08PM EST
|Bid||163.61 x 1000|
|Ask||165.85 x 2900|
|Day's Range||164.79 - 170.90|
|52 Week Range||96.81 - 177.99|
|Beta (5Y Monthly)||0.48|
|PE Ratio (TTM)||52.92|
|Earnings Date||Apr. 29, 2020 - May 03, 2020|
|Forward Dividend & Yield||1.56 (0.92%)|
|Ex-Dividend Date||Feb. 11, 2020|
|1y Target Est||164.00|
Zacks.com featured highlights include: Microsoft, Ruth???s Hospitality, ResMed, Ross Stores and Maxim Integrated Products
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
The Zacks Analyst Blog Highlights: ResMed, Ensign, DaVita, KalVista Pharmaceuticals and MEI Pharma
Medtronic (MDT) to integrate Digital Surgery's business within its Surgical Robotics arm, in turn augmenting the company's position in the field of surgical AI.
NEW YORK, Feb. 13, 2020 -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating certain officers and directors of Zuora, Inc. (NYSE:.
With the receipt of the regulatory approval, Myriad Genetics (MYGN) will be taking a major stride forward in its Oncology and Women's Health segment.
Zacks.com featured highlights include: Chipotle Mexican Grill, Vertex Pharmaceuticals, ResMed, Spirit Airlines and OneMain
Shareholder rights law firm Robbins LLP reminds investors that it is investigating whether certain officers and directors of ResMed Inc. (NYSE: RMD) breached their fiduciary duties to shareholders. ResMed develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing.